Dear investors, partners, supporters and friends, we closed the year by increasing our marketing efforts. You might have noticed an increased frequency of linkedIn posts, which we kindly ask you to like and repost. Exhibiting at the MEDICA fair brought in a large number of customer leads which we will be following-up and bring to…
read more
English Version Schlieren, Switzerland, Munich, Germany, and Vienna, Austria, December 16, 2022 Clemedi AG concludes a license agreement for detecting latent tuberculosis with the Max Planck Society (MPG) and the Medical University of Vienna Clemedi aims to extend its tuberculosis product line to cover latent tuberculosis. This requires the ability to extract M. tuberculosis DNA…
read more Clemedi AG releases Tuberculini, its first molecular test for drug-resistant tuberculosis. Tuberculini is optimized to run on Thermo Fisher Scientific’s Ion GeneStudio S5™ System. Clemedi has developed a next-generation sequencing (NGS) based test called Tuberculini, that can recognise resistance to all major therapeutic agents used to treat tuberculosis. The assay – which received a CE-IVD…
read more
Dear investors, partners, supporters and friends,during this quarter we started our transition from a research organisation towards a sales organisation. After the successful certification of our tuberculosis product last quarter we are now focussing our efforts on marketing and sales. Fundraising We are actively raising funds to finance our market entry in Europe and India…
read more
Dear investors, partners, supporters and friends,we have reached an important milestone and have brought our first product, Tuberculini, to market as a CE-IVD marked medical device. Product Development We have self-certified our product Tuberculini in Germany. It is intended to genotype M. tuberculosis bacteria found in a sample of patients confirmed with tuberculosis. The product…
read more
Dear investors, partners, supporters and friends,a lot has happened since the year started and in the following update I will briefly inform you of the major developments. Business Development We have secured a commercial use agreement with our largest supplier, ThermoFisherScientific. This will allow us to use components from Thermo inside out IVD Kits whilst…
read more